Tregs can slower development of atherosclerosis by inhibiting immune overactivity of effector T cells and secrete major anti-inflammatory cytokines, such as interleukin-10 (IL-10) and transforming growth factor (TGF-β), which are able to reduce inflammatory response in atherosclerosis [7]. This evidence concerns the gene TGFB1 and atherosclerosis.